WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non–Small Cell Lung Cancer

Amanda L. Richer(St. Joseph's Hospital and Medical Center), Timothy G. Whitsett(Translational Genomics Research Institute)
Cancer Research
June 26, 2017
Cited by 52


Related Papers